The Buyer's Clock: What Private Equity's Exit Backlog Means for Sellers
Two numbers published this week describe the private equity industry that most business owners will eventually negotiate with. PitchBook counts 3,332 US private equity firms that have not raised a new fund since 2021, a group the industry bluntly calls zombies, and the same research house puts the number of unsold portfolio companies at more than 33,000 as of mid-year, the largest inventory on record. For an owner weighing a sale, these are not abstract industry statistics. They describe the financial condition of the buyer sitting across the table.
The Backlog, in Plain Numbers
Private equity works on a simple cycle. A firm raises a fund from institutional investors, spends roughly five years buying companies, spends the next five improving and selling them, and returns the proceeds. The sale proceeds fund the investors' commitments to the next fund, and the cycle repeats. That cycle is now visibly jammed.
At the end of June 2026, sponsors held 33,575 unsold portfolio companies, by some estimates roughly $3.8 trillion in value. Average holding periods have stretched to about seven years, well beyond the four to five years the model was built around, and roughly half of all sponsor-owned companies have now been held for more than four years.
The strain shows up at the fund level too. A fund that reaches the end of its planned life still holding companies is known as a zombie fund. One analysis puts the capital sitting in such funds at $1.2 trillion, about 12 percent of global private equity assets, a figure that has nearly tripled since 2019. In a recent survey of institutional investors representing more than $2 trillion in commitments, 54 percent said they expect their exposure to these stranded funds to grow over the next two years.
A firm that cannot sell cannot easily raise. That is how 3,332 managers end up frozen at their 2021 fund. Management fees, which one estimate puts near $20 billion a year on this stagnant capital, allow many of them to keep the lights on without doing new deals.
How the Industry Got Here
The jam has a specific origin. Between 2018 and 2021, private equity raised and deployed capital at the fastest pace in its history, buying companies at peak multiples supported by near-zero interest rates. When rates reset in 2022, the math on those purchases stopped working. Selling at today's prices would mean recognizing losses; holding means waiting and paying more expensive debt service in the meantime.
Buyers and sellers of these portfolio companies have spent four years apart on price, and the standoff rolls downhill. Fewer exits mean fewer distributions to institutional investors, which means those investors have less cash to commit to new funds, which means fewer firms can raise. The University of California system's sale of $1 billion in fund stakes this week is what the pressure release looks like at the institutional level.
None of this means private equity is going away. The industry still holds near-record uncommitted capital, and Goldman Sachs said this week that it expects sponsors to join a merger wave that has already reached $3.5 trillion this year. It means something more specific: the gap between a well-positioned buyer and a poorly positioned one has never been wider.
If a Sponsor Wants to Buy Your Company
Most owners diligence a buyer's reputation and their plans for the business. Far fewer diligence the fund itself, and in this market the fund is where the risk lives.
A sponsor investing from a recently raised fund, early in its investment period, is spending money it already has. It can move quickly, absorb a competitive price, and reserve capital for add-on acquisitions after closing. A sponsor stretching the last reserves of an aging fund, or one that has not raised since 2021, is a different counterparty. The equity check may depend on co-investors who have not yet committed. Approvals run slower. The structure tends to lean harder on debt, seller financing, and earnouts, because the buyer is bridging a capital problem, not just a valuation gap.
The fund's age matters even more if you are keeping a stake. Rollover equity, where an owner retains a minority position in the business after the sale, only pays when the sponsor eventually exits. Roll into a fund in year eight of a ten-year life and your second payday depends on a firm that is already late. Some of those positions resolve through continuation vehicles, where the sponsor sells the company to a new fund it also controls, an outcome that can extend the hold for years and deserves its own scrutiny before you sign.
If You Compete With the Backlog
The inventory affects sellers who never take a sponsor's money at all. When your business goes to market, it is not only compared with other founder-owned companies for sale. It competes for buyer attention with 33,000 sponsor-owned businesses, a growing share of which will be pushed to market as fund lives expire and investors demand liquidity.
That supply has two practical consequences. First, buyers can afford to be selective, and the data shows they are. Deal volume in the first half of 2026 fell by roughly a third from the prior year while the average deal size rose sharply, a sign that capital is concentrating in fewer, higher-conviction acquisitions. Businesses with durable earnings, diversified customers, and management depth continue to clear at full prices; everything else negotiates against the backlog. Second, timing has real value. An owner who goes to market before the forced sellers in their sector do is competing against inventory that is still being held, not inventory that is being cleared.
Questions to Ask a Private Equity Buyer
- Which fund is acquiring the business, what year was it raised, and when does its investment period end?
- How much uncalled capital remains in that fund, and does the equity check depend on co-investment or further fundraising?
- What has the firm actually sold in the last three years? Realizations tell you more than portfolio markups.
- Has the firm raised a successor fund since 2021? If not, ask why, and weigh the answer.
- If you are rolling equity, how long does the sponsor expect to hold, and what happens to your stake if the hold extends past the fund's term?
- Who has to approve the deal internally, and has the investment committee reviewed it before the letter of intent?
What to Watch From Here
Three developments will determine how quickly the jam clears. The first is the secondaries market, which trades existing fund stakes and portfolio companies. GP-led secondary transactions grew from $48 billion in 2022 to $106 billion in 2025, and sales by institutions, like the University of California's this week, are accelerating. Every transaction there releases pressure without a traditional sale. The second is the cost of debt. Each move in rates changes the math on thousands of held companies at once, and cheaper financing would reopen exits that current lending terms keep shut. The third is consolidation among the firms themselves. Managers that cannot raise will wind down, sell their portfolios, or merge into larger platforms, and their companies will come to market as that happens.
The Bottom Line
The private equity firms bidding on businesses today range from freshly capitalized to quietly stranded, and the same headline price from two different funds can carry very different probabilities of closing and very different post-close experiences. Before you sign a letter of intent, diligence the buyer's fund with the same rigor the buyer will apply to your books: when it was raised, what remains in it, what it has returned, and what happens to your proceeds and your rolled equity if the clock runs out. In this market, the strongest offer is not always the largest number. It is the one backed by capital that already exists.